Here are three insights:
1. The project is valued at $100 million.
2. Researchers will attempt to treat paralysis, depression, amputation, epilepsy and more.
3. The researchers will leverage a digital nervous system powered by optogenetics to try to treat paralysis and Parkinson’ disease. The end goal involves creating cells and tissues to grow organs that will repair biological parts.
More articles on devices:
TransEnterix submits additional information for surgical robotic system FDA clearance: 5 insights
Dr. Asif Ilyas completes 1st surgery using Globus Medical’s trauma fixation system: 5 takeaways
NuVasive, DePuy Synthes, Zimmer Biomet & more: 10 device company notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
